SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001415889-24-004155
Filing Date
2024-02-16
Accepted
2024-02-16 16:40:35
Documents
1
Period of Report
2024-01-04

Document Format Files

Seq Description Document Type Size
1 form4a-02162024_090222.html 4/A  
1 form4a-02162024_090222.xml 4/A 6974
  Complete submission text file 0001415889-24-004155.txt   8520
Mailing Address 18706 NORTH CREEK PARKWAY, SUITE 104 BOTHELL WA 98011
Business Address 18706 NORTH CREEK PARKWAY, SUITE 104 BOTHELL WA 98011 (425) 620-8501
Athira Pharma, Inc. (Issuer) CIK: 0001620463 (see all company filings)

IRS No.: 453368487 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O ATHIRA PHARMA, INC. 18706 NORTH CREEK PARKWAY, SUITE 104 BOTHELL WA 98011
Business Address
Lenington Rachel (Reporting) CIK: 0001861194 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-39503 | Film No.: 24649037